- Home
- / XyloCor Therapeutics
XyloCor Therapeutics
Total Funding
$17 M
XyloCor Therapeutics Summary
Company Summary
- Overview
- XyloCor Therapeutic is a biopharmaceutical company which is engaged in developing of gene therapy for cardiovascular diseases. The Company develops products for patients with refractory angina and cardiac tissue damage from heart attacks.
- Type
- Private
- Status
- Active
- Founded
- 2013
- HQ
- Malvern, PA, US | view all locations
- Website
- http://xylocor.com/
- Cybersecurity rating
Table of Contents
Key People
Dawn Byrnes, VP, Clinical Operations
Glenn Batchelder, Executive Chairman
Ronald Crystal, Board Observer, Founder and Advisor
LocationsView all
2 locations detected
Malvern, PA HQ
United States
39 ADDISON LANE, Malvern, Pennsylvania, 19355, United States
Chesterbrook, PA
United States
1200 Liberty Ridge Dr #120